D.E. Shaw & Co’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$827K Sell
9,146
-22,965
-72% -$2.11M ﹤0.01% 3564
2025
Q4
$2.89M Buy
+32,111
New +$3.04M ﹤0.01% 2751
2025
Q2
Sell
-46,228
Closed -$5.23M 4783
2025
Q1
$5.23M Sell
46,228
-270,537
-85% -$28.9M ﹤0.01% 1855
2024
Q4
$33.5M Sell
316,765
-53,250
-14% -$5.71M 0.02% 749
2024
Q3
$39.9M Sell
370,015
-120,123
-25% -$13.1M 0.03% 618
2024
Q2
$53.2M Buy
490,138
+375,929
+329% +$44.3M 0.05% 436
2024
Q1
$15.1M Sell
114,209
-47,701
-29% -$5.96M 0.01% 1099
2023
Q4
$19.7M Buy
161,910
+72,252
+81% +$8.06M 0.02% 930
2023
Q3
$10.1M Buy
89,658
+14,150
+19% +$1.8M 0.01% 1281
2023
Q2
$11M Sell
75,508
-8,047
-10% -$1.09M 0.01% 1266
2023
Q1
$10.8M Buy
83,555
+65,621
+366% +$8.24M 0.01% 1305
2022
Q4
$2.29M Sell
17,934
-62,531
-78% -$7.26M ﹤0.01% 2829
2022
Q3
$8.41M Sell
80,465
-50,945
-39% -$5.59M 0.01% 1501
2022
Q2
$13.8M Sell
131,410
-282,837
-68% -$33.6M 0.02% 1144
2022
Q1
$53M Sell
414,247
-639,477
-61% -$77.1M 0.05% 465
2021
Q4
$130M Buy
1,053,724
+349,717
+50% +$45.8M 0.11% 197
2021
Q3
$100M Sell
704,007
-258,141
-27% -$38M 0.09% 255
2021
Q2
$150M Buy
962,148
+421,809
+78% +$68.3M 0.13% 156
2021
Q1
$84M Buy
540,339
+220,790
+69% +$34.2M 0.08% 289
2020
Q4
$47.8M Buy
319,549
+133,294
+72% +$18.8M 0.04% 512
2020
Q3
$24.6M Sell
186,255
-112,432
-38% -$14.7M 0.03% 721
2020
Q2
$34.6M Sell
298,687
-133,284
-31% -$15.4M 0.04% 507
2020
Q1
$42.4M Buy
431,971
+290,070
+204% +$38M 0.07% 329
2019
Q4
$20.6M Sell
141,901
-39,604
-22% -$5.47M 0.02% 803
2019
Q3
$24.2M Sell
181,505
-680,594
-79% -$87.9M 0.03% 690
2019
Q2
$98.5M Buy
862,099
+489,926
+132% +$57.4M 0.12% 198
2019
Q1
$46.1M Sell
372,173
-443,662
-54% -$50.4M 0.06% 405
2018
Q4
$82.2M Buy
815,835
+371,075
+83% +$41.7M 0.11% 202
2018
Q3
$56.8M Buy
444,760
+73,876
+20% +$8.78M 0.07% 355
2018
Q2
$40.1M Buy
370,884
+61,065
+20% +$6.65M 0.05% 442
2018
Q1
$32.8M Sell
309,819
-1,962
-0.6% -$228K 0.04% 477
2017
Q4
$36.5M Buy
311,781
+85,605
+38% +$9.68M 0.05% 439
2017
Q3
$25.7M Buy
226,176
+38,756
+21% +$4.47M 0.04% 517
2017
Q2
$23.4M Sell
187,420
-648,948
-78% -$76.9M 0.04% 533
2017
Q1
$99.2M Sell
836,368
-273,171
-25% -$31M 0.17% 130
2016
Q4
$111M Sell
1,109,539
-5,042
-0.5% -$540K 0.19% 110
2016
Q3
$141M Sell
1,114,581
-183,320
-14% -$22.6M 0.25% 76
2016
Q2
$152M Sell
1,297,901
-123,818
-9% -$14M 0.28% 69
2016
Q1
$147M Sell
1,421,719
-147,242
-9% -$14.2M 0.26% 79
2015
Q4
$156M Buy
1,568,961
+844,268
+117% +$82.6M 0.23% 93
2015
Q3
$66.1M Buy
724,693
+578,610
+396% +$58M 0.1% 253
2015
Q2
$15.5M Sell
146,083
-451,964
-76% -$50M 0.02% 742
2015
Q1
$68.2M Buy
598,047
+318,148
+114% +$36.3M 0.1% 218
2014
Q4
$30.8M Sell
279,899
-28,857
-9% -$3.04M 0.04% 516
2014
Q3
$30.1M Sell
308,756
-255,179
-45% -$25.1M 0.04% 511
2014
Q2
$56.9M Buy
563,935
+173,306
+44% +$16.9M 0.08% 294
2014
Q1
$35.9M Buy
390,629
+379,711
+3,478% +$35M 0.05% 402
2013
Q4
$988K Sell
10,918
-1,332
-11% -$115K ﹤0.01% 3179
2013
Q3
$977K Sell
12,250
-31,094
-72% -$2.45M ﹤0.01% 3060
2013
Q2
$3.15M Buy
+43,344
New +$3.24M 0.01% 1697

Other funds holding ZBH

D.E. Shaw & Co's ZBH Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Zimmer Biomet (ZBH) stake by 72% in Q1 2026, selling an estimated $2.11M and leaving 9,146 shares worth $827K. The position accounts for ﹤0.01% of the portfolio, ranked #3564.

D.E. Shaw & Co first reported a position in ZBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $156M in Q4 2015. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • D.E. Shaw & Co held 9,146 shares of Zimmer Biomet worth $827K as of Q1 2026.
  • D.E. Shaw & Co sold 22,965 Zimmer Biomet shares in Q1 2026, an estimated $2.11M.
  • Zimmer Biomet made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3564 holding.
  • D.E. Shaw & Co first reported a position in Zimmer Biomet in Q2 2013 and has held it in 50 quarters since.
  • D.E. Shaw & Co's Zimmer Biomet position peaked at $156M in Q4 2015.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.